BNTX
Price
$94.78
Change
+$1.98 (+2.13%)
Updated
May 8 closing price
Capitalization
22.31B
87 days until earnings call
ORMP
Price
$2.29
Change
+$0.07 (+3.15%)
Updated
May 8 closing price
Capitalization
93.55M
19 days until earnings call
Ad is loading...

BNTX vs ORMP

Header iconBNTX vs ORMP Comparison
Open Charts BNTX vs ORMPBanner chart's image
BioNTech SE American Depositary Share
Price$94.78
Change+$1.98 (+2.13%)
Volume$966.18K
Capitalization22.31B
Oramed Pharmaceuticals
Price$2.29
Change+$0.07 (+3.15%)
Volume$44.41K
Capitalization93.55M
BNTX vs ORMP Comparison Chart
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTX vs. ORMP commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Hold and ORMP is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BNTX: $94.78 vs. ORMP: $2.29)
Brand notoriety: BNTX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 83% vs. ORMP: 49%
Market capitalization -- BNTX: $22.31B vs. ORMP: $93.55M
BNTX [@Biotechnology] is valued at $22.31B. ORMP’s [@Biotechnology] market capitalization is $93.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • BNTX’s TA Score: 3 bullish, 8 bearish.
  • ORMP’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а -7.47% price change this week, while ORMP (@Biotechnology) price change was +0.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

BNTX is expected to report earnings on Aug 04, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($22.3B) has a higher market cap than ORMP($93.5M). BNTX has higher P/E ratio than ORMP: BNTX (161.76) vs ORMP (20.91). ORMP YTD gains are higher at: -5.372 vs. BNTX (-16.823). ORMP has higher annual earnings (EBITDA): 9.44M vs. BNTX (-367.1M). BNTX has more cash in the bank: 16.8B vs. ORMP (142M). ORMP has less debt than BNTX: ORMP (429K) vs BNTX (254M). BNTX has higher revenues than ORMP: BNTX (2.75B) vs ORMP (0).
BNTXORMPBNTX / ORMP
Capitalization22.3B93.5M23,850%
EBITDA-367.1M9.44M-3,890%
Gain YTD-16.823-5.372313%
P/E Ratio161.7620.91774%
Revenue2.75B0-
Total Cash16.8B142M11,831%
Total Debt254M429K59,207%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
79
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRAM0.04N/A
N/A
GOLD FLORA CORP.
BAYRY6.64-0.01
-0.15%
Bayer A.G.
NGENF2.57-0.02
-0.68%
NervGen Pharma Corp.
PUBGY25.58-0.34
-1.31%
Publicis Groupe S.A.
BDNNY61.10-1.43
-2.29%
Boliden AB

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with TIL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+2.13%
TIL - BNTX
55%
Loosely correlated
+5.42%
MRNA - BNTX
50%
Loosely correlated
+1.33%
CVAC - BNTX
46%
Loosely correlated
+3.46%
ARCT - BNTX
44%
Loosely correlated
+3.93%
AXON - BNTX
43%
Loosely correlated
+14.13%
More